SCM
ABBV icon

Sterneck Capital Management’s AbbVie ABBV Stock Holding History

Sterneck Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,570
Closed -$386K – 105
2021
Q1 		$386K Buy
+3,570
New +$382K 0.27% 55
2014
Q2 		– Sell
-11,511
Closed -$592K – 128
2014
Q1 		$592K Sell
11,511
-3,979
-26% -$201K 0.32% 73
2013
Q4 		$818K Sell
15,490
-759
-5% -$37.3K 0.5% 64
2013
Q3 		$727K Sell
16,249
-2,079
-11% -$92.2K 0.46% 67
2013
Q2 		$758K Buy
+18,328
New +$802K 0.48% 65

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Sterneck Capital Management's ABBV Position: Q2 2021 in Review

Sterneck Capital Management sold out of AbbVie (ABBV) in Q2 2021, closing a stake of 3,570 shares — an estimated $386K sold.

Sterneck Capital Management first reported a position in ABBV in Q2 2013 and held it in 5 quarters. The position peaked at $818K in Q4 2013. 2,677 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

  • Sterneck Capital Management reported no remaining AbbVie position as of Q2 2021 after selling out during the quarter.
  • Sterneck Capital Management sold 3,570 AbbVie shares in Q2 2021, an estimated $386K.
  • Sterneck Capital Management first reported a position in AbbVie in Q2 2013 and held it in 5 quarters.
  • Sterneck Capital Management's AbbVie position peaked at $818K in Q4 2013.
  • 2,677 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on Sterneck Capital Management's 13F filing for Q2 2021, filed 30 Jul 2021.